Publicacions (24) Publicacions de SAUL ALVAREZ TEIJEIRO

2024

  1. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  2. Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment

    International journal of molecular sciences, Vol. 25, Núm. 8

2023

  1. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  4. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. An intrinsic temporal order of c-JUN N-terminal phosphorylation regulates its activity by orchestrating co-factor recruitment

    Nature Communications, Vol. 13, Núm. 1

  2. Pathobiological functions and clinical implications of annexin dysregulation in human cancers

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors

    Molecular and Cellular Proteomics, Vol. 21, Núm. 7

2020

  1. Transition to naïve human pluripotency mirrors pan-cancer DNA hypermethylation

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Frequent alteration of annexin A9 and A10 in HPV-negative head and neck squamous cell carcinomas: Correlation with the histopathological differentiation grade

    Journal of Clinical Medicine, Vol. 8, Núm. 2

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. Factors secreted by cancer-associated fibroblasts that sustain cancer stem properties in head and neck squamous carcinoma cells as potential therapeutic targets

    Cancers, Vol. 10, Núm. 9

  3. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813

2017

  1. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b

    Scientific Reports, Vol. 7, Núm. 1

  2. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells

    Oncotarget, Vol. 8, Núm. 8, pp. 13716-13729

  3. Dysregulation of miR-196b in head and neck cancers leads to pleiotropic effects in the tumor cells and surrounding stromal fibroblasts

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma

    Head and Neck, Vol. 38, Núm. 11, pp. 1672-1678

  2. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: Evidence for regulation by epigenetic mechanisms

    Scientific Reports, Vol. 6

  3. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793